Related Experiment Videos

Antisense Oligonucleotide-Based Therapy for Neuromuscular Disease

Valentina Sardone1, Haiyan Zhou2, Francesco Muntoni3,4

  • 1Dubowitz Neuromuscular Centre, Molecular Neurosciences Section, Developmental Neuroscience Programme, UCL Great Ormond Street Institute of Child Health, London WC1N 1EH, UK. v.sardone@ucl.ac.uk.

Summary

Antisense oligonucleotides offer promising new therapies for neurodegenerative neuromuscular disorders like Duchenne Muscular Dystrophy. These nucleic acid molecules modulate protein expression, with ongoing research focusing on improved delivery and reduced toxicity for better clinical efficacy.

Related Concept Videos